Feature
•

Pfizer refuses to provide information on new vaccine deal

The US pharmaceutical company Pfizer has renegotiated a contract from 2021 with the EU Commission. According to media reports, several hundred million euros in cancellation fees are at stake for Germany alone. The European Parliament wants to clarify the background. But instead of answers, Pfizer sends a catalog of questions.
By
Eric Bonse
Image of Eric Bonse

US pharmaceutical company Pfizer is refusing to provide information about an agreement to newly regulate a controversial, multibillion-dollar EU vaccine purchase from 2021. Instead of responding to questions from MPs on the COVI special committee looking into the Covid-19 crisis, the company sent a list of questions and refused to allow access to files. According to the Parliament, this is unacceptable.

Continue reading now

… and get free access to this Professional Briefing for a month.

Continue free reading

Are you already a guest at the Europe.Table? Log in now

Related

    CBAM launch triggers CO2 pricing worldwide
    Digital decade: big plans, small steps
    China: Merics warns of manipulation
    Robert Fico – Slovakia’s political stalwart
Be our guest at the Europe.Table. Try it for free now, no automatic renewal.
Try it for free